A quantitative assay for the in vitro determination of rat NGAL in urine, plasma, serum, tissue extracts or culture media.
Rat NGAL ELISA Kit
Request Price

×
Request Price
"*" indicates required fields
×
(+45) 45 29 00 00 | info@bioporto.com
A quantitative assay for the in vitro determination of rat NGAL in urine, plasma, serum, tissue extracts or culture media.
"*" indicates required fields
Product Summary
Scientific References
23147732 – Pai MP, Chen WZ, Garba A, Cui H, Zaffo B, El-Fawal HA, Mousa SA (2013) Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model. Antimicrob Agents Chemother. 57:716-722
23364806 – Sohotnik R, Nativ O, Abbasi A, Awad H, Frajewicki V, Bishara B, Sukhotnik I, Armaly Z, Aronson D, Heyman SN, Nativ O, Abassi Z (2013) Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol. 304:1099-1104
23331620 – Sultan S, Cameron S, Ahmad S, Malik IA, Schultze FC, Hielscher R, Rave-Frank M, Hess CF, Ramadori G, Christiansen H (2013) Serum Lipocalin2 is a potential biomarker of liver irradiation damage. Liver Int. 33:459-468
22621967 – Bohn AB, Norregaard R, Stodkilde L, Wang Y, Bertelsen LB, Fenton RA, Matchkov VV, Bouzinova EV, Horsman MR, Frokiaer J, Stodkilde-Jorgensen H (2012) Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output. Am J Physiol Regul Integr Comp Physiol. 303:186-198
22492942 – Giani JF, Burghi V, Veiras LC, Tomat A, Munoz MC, Cao G, Turyn D, Toblli JE, Dominici FP (2012) Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats. Am J Physiol Renal Physiol. 302:1606-1615
23147732 – Pai MP, Chen WZ, Garba A, Cui H, Zaffo B, El-Fawal HA, Mousa SA (2013) Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model. Antimicrob Agents Chemother. 57:716-722
23364806 – Sohotnik R, Nativ O, Abbasi A, Awad H, Frajewicki V, Bishara B, Sukhotnik I, Armaly Z, Aronson D, Heyman SN, Nativ O, Abassi Z (2013) Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol. 304:1099-1104
23331620 – Sultan S, Cameron S, Ahmad S, Malik IA, Schultze FC, Hielscher R, Rave-Frank M, Hess CF, Ramadori G, Christiansen H (2013) Serum Lipocalin2 is a potential biomarker of liver irradiation damage. Liver Int. 33:459-468
22621967 – Bohn AB, Norregaard R, Stodkilde L, Wang Y, Bertelsen LB, Fenton RA, Matchkov VV, Bouzinova EV, Horsman MR, Frokiaer J, Stodkilde-Jorgensen H (2012) Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output. Am J Physiol Regul Integr Comp Physiol. 303:186-198
22492942 – Giani JF, Burghi V, Veiras LC, Tomat A, Munoz MC, Cao G, Turyn D, Toblli JE, Dominici FP (2012) Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats. Am J Physiol Renal Physiol. 302:1606-1615